Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Oct 26, 2016 at 7:15 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The October 14 short interest data have been compared with the previous report, and short interest moves in these selected…

Chris Lange | Oct 25, 2016 at 4:09 PM EDT

Is This the Beginning of the End of a Dipexium Implosion?

Dipexium Pharmaceuticals Inc. (NASDAQ: DPRX) is watching its shares in free fall on Tuesday after the company announced data from…

Chris Lange | Oct 24, 2016 at 12:35 PM EDT

What to Expect From Merck Earnings

Merck is scheduled to release its third-quarter earnings report after before the markets open on Tuesday.

Chris Lange | Oct 24, 2016 at 12:05 PM EDT

What to Look for When Eli Lilly Reports Earnings

Eli Lilly plans to release its most recent earnings report before the markets open on Tuesday, and analysts expect top…

Jon C. Ogg | Oct 24, 2016 at 11:50 AM EDT

Why Negative Analyst Views May Matter So Much on Ariad

Ariad Pharmaceuticals shares were down handily on Monday after JPMorgan downgraded the stock. Also Senator Sanders recently asked about the…

Chris Lange | Oct 24, 2016 at 10:15 AM EDT

aTyr Receives FDA Fast Track Designation

aTyr Pharma watched its shares climb early on Monday after the company announced that its product candidate Resolaris was granted…

Chris Lange | Oct 24, 2016 at 10:05 AM EDT

Inovio Pharma Tanks on FDA Clinical Hold

Shares of Inovio Pharmaceuticals slid in Monday’s session on news that the FDA placed a clinical hold on a proposed…

Jon C. Ogg | Oct 24, 2016 at 7:55 AM EDT

Are Alkermes Analysts Chasing This Story Too Hard, or Is It Just a Start?

Is it possible that analysts are now behind the curve on Alkermes? Or worse, are they chasing their expectations too…

Chris Lange | Oct 23, 2016 at 10:35 AM EDT

Top Health Care Earnings Coming Next Week

Earnings season is now in full swing, and we have put together a preview of Bristol-Myers, AbbVie and some of…

Douglas A. McIntyre | Oct 21, 2016 at 9:10 AM EDT

2 Diet Drinks a Day Could Double Diabetes Risk

The European Society of Endocrinology has just published a study about diabetes risks that soda manufacturers will not like.

Trey Thoelcke | Oct 21, 2016 at 7:45 AM EDT

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Alkermes' positive Phase 3 results for its novel antidepressant is serving as a rising tide — a storm surge even…

Jon C. Ogg | Oct 20, 2016 at 4:15 PM EDT

Would a Varian Acquisition by GE Help GE in Its Long-Term Goals?

Varian shares were up as much as 10% on Thursday after a report that GE might be acquiring the medical…

Chris Lange | Oct 20, 2016 at 12:35 PM EDT

Why Rigel Pharma Is Falling

Rigel Pharmaceuticals shares slid on Thursday after the company announced results from its late-stage clinical trial.

Jon C. Ogg | Oct 20, 2016 at 12:25 PM EDT

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

Americans generally would like to spend less money on health care. One way that this can be and will be…

Lee Jackson | Oct 20, 2016 at 9:55 AM EDT

Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains

These top biotech companies have been absolutely hammered and now trade at a valuation much lower than large cap pharmaceuticals.

1 … 188 189 190 191 192 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Is This the Beginning of the End of a Dipexium Implosion?

What to Expect From Merck Earnings

What to Look for When Eli Lilly Reports Earnings

Why Negative Analyst Views May Matter So Much on Ariad

aTyr Receives FDA Fast Track Designation

Inovio Pharma Tanks on FDA Clinical Hold

Are Alkermes Analysts Chasing This Story Too Hard, or Is It Just a Start?

Top Health Care Earnings Coming Next Week

2 Diet Drinks a Day Could Double Diabetes Risk

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Would a Varian Acquisition by GE Help GE in Its Long-Term Goals?

Why Rigel Pharma Is Falling

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains

Tom Lee’s ‘Granny Shots’ ETF Is Beating the S&P Again, and He’s Calling for 8,000

If You Just Inherited an IRA, Read This

Tesla Is Still Down 17% in 2026. Can Wednesday’s Earnings Event Get TSLA Stock Back on Track?

If You Just Inherited an IRA, Read This

She's a 62-Year-Old Widow Banking on the COLA Raise. The Survivor-Benefit Timing She's Ignoring Is Worth Far More.

Tom Lee’s ‘Granny Shots’ ETF Is Beating the S&P Again, and He’s Calling for 8,000

If You Just Inherited an IRA, Read This

Health and Healthcare Articles

All Health and Healthcare Articles

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Is This the Beginning of the End of a Dipexium Implosion?

What to Expect From Merck Earnings

What to Look for When Eli Lilly Reports Earnings

Why Negative Analyst Views May Matter So Much on Ariad

aTyr Receives FDA Fast Track Designation

Inovio Pharma Tanks on FDA Clinical Hold

Are Alkermes Analysts Chasing This Story Too Hard, or Is It Just a Start?

Top Health Care Earnings Coming Next Week

2 Diet Drinks a Day Could Double Diabetes Risk

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Would a Varian Acquisition by GE Help GE in Its Long-Term Goals?

Why Rigel Pharma Is Falling

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains

Tom Lee’s ‘Granny Shots’ ETF Is Beating the S&P Again, and He’s Calling for 8,000

If You Just Inherited an IRA, Read This

Tesla Is Still Down 17% in 2026. Can Wednesday’s Earnings Event Get TSLA Stock Back on Track?

Featured Reads

If You Just Inherited an IRA, Read This

She's a 62-Year-Old Widow Banking on the COLA Raise. The Survivor-Benefit Timing She's Ignoring Is Worth Far More.